Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma

Pediatrics

Volumn 126, Issue 3, 2010, Pages

  Eid, Nemr S ^a   Noonan, Michael J ^b   Chipps, Bradley ^c   Parasuraman, Bhash ^d   Miller, Christopher J ^d   O'Brien, Christopher D ^d  

^a Cystic Fibrosis Center   (United States)

^b Allergy Associates Research Center   (United States)

^c Capital Allergy and Respiratory Disease Center   (United States)

^d ASTRAZENECA   (United Kingdom)

Author keywords

Adolescents; Asthma; Children; Combination therapy; Once daily dosing

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; SALBUTAMOL; BRONCHODILATING AGENT; BUDESONIDE; ETHANOLAMINE DERIVATIVE; FORMOTEROL;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; ASTHMA; BACTERIAL RESPIRATORY TRACT INFECTION; BLOOD SAMPLING; CHILD; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; EPISTAXIS; EVENING DOSAGE; FEMALE; FEVER; FOLLOW UP; FORCED EXPIRATORY FLOW; HEADACHE; HUMAN; HYDROCORTISONE URINE LEVEL; INFLUENZA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; MUSCULOSKELETAL CHEST PAIN; NAUSEA; NEBULIZATION; OTITIS MEDIA; PEAK EXPIRATORY FLOW; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SINUSITIS; SORE THROAT; STREPTOCOCCAL PHARYNGITIS; THRUSH; UPPER RESPIRATORY TRACT INFECTION; URINALYSIS; VIRAL UPPER RESPIRATORY TRACT INFECTION; VOMITING; COMPARATIVE STUDY; DRUG ADMINISTRATION;

ADOLESCENT; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ETHANOLAMINES; FEMALE; HUMANS; MALE;

EID: 77956284992     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-2970     Document Type: Article

References (15)

1. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program expert panel report 3: guidelines for the diagnosis and management of asthma - full report 2007. Publication no. 08-4051. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed September 19, 2007
2. Bisgaard H, Le Roux P, Bjåmer D, Dymek A, Vermeulen JH, Hultquist C. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest. 2006;130(6):1733-1743 (Pubitemid 46033427)
3. Buhl R, Creemers JP, Vondra V, Martelli NA, Naya IP, Ekström T. Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma. Respir Med. 2003;97(4):323-330
4. Kuna P, Creemers JP, Vondra V, et al. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma. Respir Med. 2006;100(12):2151-2159
5. Kerwin EM, Oppenheimer JJ, LaForce C, et al. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing. Ann Allergy Asthma Immunol. 2009;103(1):62-72
6. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Resp Dis. 1987;136(1):225-244
7. National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma update on selected topics - 2002 [published correction appears in J Allergy Clin Immunol. 2003;111(3):466] J Allergy Clin Immunol. 2002;110(5 suppl):S141-S219
8. Murphy K, Nelson H, Parasuraman B, Boggs R, Miller C, O'Dowd L. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma. Curr Med Res Opin. 2008;24(3):879-894 (Pubitemid 351428999)
9. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in children with asthma. Qual Life Res. 1996;5(1):35-46
10. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in the parents of children with asthma. Qual Life Res. 1996;5(1):27-34 (Pubitemid 26100500)
11. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol. 1994;47(1):81-87
12. Masoli M, Williams M, Weatherall M, Beasley R. The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler. Respir Med. 2006;100(1):20-25 (Pubitemid 43033375)
13. Lötvall J, Langley S, Woodcock A. Inhaled steroid/long-acting β2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients. Respir Res. 2006;7:110
14. Tal A, Simon G, Vermeulen JH, et al. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma. Pediatr Pulmonol. 2002;34(5):342-350
15. Kramer JM. Balancing the benefits and risks of inhaled long-acting beta-agonists: the influence of values. N Engl J Med. 2009; 360(16):1592-1595